Pines Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.67M Buy
3,323
+91
+3% +$43.7K 0.48% 55
2026
Q1
$1.59M Sell
3,232
-7
-0.2% -$3.8K 0.51% 48
2025
Q4
$1.88M Buy
3,239
+449
+16% +$254K 0.61% 34
2025
Q3
$1.35M Sell
2,790
-30
-1% -$14K 0.46% 52
2025
Q2
$1.21M Buy
2,820
+207
+8% +$86.5K 0.43% 56
2025
Q1
$1.1M Buy
2,613
+200
+8% +$108K 0.51% 48
2024
Q4
$1.31M Buy
+2,413
New +$1.33M 0.57% 41

Other funds holding TMO

Pines Wealth Management's TMO Position: Q2 2026 in Review

Pines Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 2.8% in Q2 2026, buying an estimated $43.7K and bringing the position to 3,323 shares worth $1.67M. The position accounts for 0.48% of the portfolio, ranked #55.

Pines Wealth Management first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.88M in Q4 2025. 800 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Pines Wealth Management held 3,323 shares of Thermo Fisher Scientific worth $1.67M as of Q2 2026.
  • Pines Wealth Management bought 91 Thermo Fisher Scientific shares in Q2 2026, an estimated $43.7K.
  • Thermo Fisher Scientific made up 0.48% of Pines Wealth Management's portfolio in Q2 2026, its #55 holding.
  • Pines Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • Pines Wealth Management's Thermo Fisher Scientific position peaked at $1.88M in Q4 2025.
  • 800 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Pines Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.